EDP Biotech Detects Early Stage Colon Cancer
Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a […]
Identification and detection of new biomarkers that identify the beginning stages of diseases is critical for achieving successful medical treatment. EDP Biotech Corporation is a […]
Women should be aware that they have several options for colon cancer screening, and not only the often-dreaded colonoscopy, according to a new report from the American College of Obstetricians and Gynecologists.
More Americans are getting tested for colon cancer and breast cancer, the U.S. Centers for Disease Control (CDC) recently reported, but the numbers still aren’t high enough.
Genomic Health, a developer of genomics-based diagnostic tests, announced on Thursday the worldwide availability of its Oncotype DX Colon Cancer Test.
The Los Angeles-based company discussed its recent clinical trials, including results from a Phase I study of ICT-107 to treat a deadly form of brain cancer called glioblastoma.
The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector.
Scientists in Switzerland may have found a way to inhibit the growth of colon cancer in humans, says a new study published in EMBO Molecular Medicine.
A new genetic discovery could lead to easier detection of colorectal cancer.
Copyright © 2024 | WordPress Theme by MH Themes